nodes	percent_of_prediction	percent_of_DWPC	metapath
Tacrolimus—ABCB1—Parkinson's disease	0.522	1	CbGaD
Tacrolimus—PPP3CA—pons—Parkinson's disease	0.0206	0.113	CbGeAlD
Tacrolimus—PPP3CA—telencephalic ventricle—Parkinson's disease	0.017	0.0929	CbGeAlD
Tacrolimus—MTOR—forelimb—Parkinson's disease	0.0144	0.079	CbGeAlD
Tacrolimus—PPP3CA—hindbrain—Parkinson's disease	0.00801	0.0438	CbGeAlD
Tacrolimus—MTOR—hindbrain—Parkinson's disease	0.00592	0.0324	CbGeAlD
Tacrolimus—ABCA5—medulla oblongata—Parkinson's disease	0.00474	0.0259	CbGeAlD
Tacrolimus—PPP3CA—brainstem—Parkinson's disease	0.00459	0.0251	CbGeAlD
Tacrolimus—PPP3CA—forebrain—Parkinson's disease	0.00443	0.0242	CbGeAlD
Tacrolimus—ABCA5—midbrain—Parkinson's disease	0.00433	0.0237	CbGeAlD
Tacrolimus—ABCA5—spinal cord—Parkinson's disease	0.00423	0.0231	CbGeAlD
Tacrolimus—ABCA5—head—Parkinson's disease	0.00376	0.0206	CbGeAlD
Tacrolimus—PPP3CA—cardiovascular system—Parkinson's disease	0.00375	0.0205	CbGeAlD
Tacrolimus—MTOR—embryo—Parkinson's disease	0.0037	0.0203	CbGeAlD
Tacrolimus—ABCA5—nervous system—Parkinson's disease	0.00356	0.0195	CbGeAlD
Tacrolimus—ABCA5—central nervous system—Parkinson's disease	0.00343	0.0188	CbGeAlD
Tacrolimus—MTOR—brainstem—Parkinson's disease	0.00339	0.0186	CbGeAlD
Tacrolimus—ABCA5—cerebellum—Parkinson's disease	0.00335	0.0183	CbGeAlD
Tacrolimus—MTOR—forebrain—Parkinson's disease	0.00327	0.0179	CbGeAlD
Tacrolimus—PPP3CA—medulla oblongata—Parkinson's disease	0.0032	0.0175	CbGeAlD
Tacrolimus—FKBP1A—forebrain—Parkinson's disease	0.00294	0.0161	CbGeAlD
Tacrolimus—PPP3CA—midbrain—Parkinson's disease	0.00293	0.016	CbGeAlD
Tacrolimus—PPP3CA—spinal cord—Parkinson's disease	0.00286	0.0156	CbGeAlD
Tacrolimus—MTOR—cardiovascular system—Parkinson's disease	0.00277	0.0151	CbGeAlD
Tacrolimus—ABCA5—brain—Parkinson's disease	0.00272	0.0149	CbGeAlD
Tacrolimus—PPP3CA—head—Parkinson's disease	0.00254	0.0139	CbGeAlD
Tacrolimus—FKBP1A—cardiovascular system—Parkinson's disease	0.00249	0.0136	CbGeAlD
Tacrolimus—PPP3CA—nervous system—Parkinson's disease	0.00241	0.0132	CbGeAlD
Tacrolimus—PPP3CA—central nervous system—Parkinson's disease	0.00232	0.0127	CbGeAlD
Tacrolimus—PPP3CA—cerebellum—Parkinson's disease	0.00226	0.0124	CbGeAlD
Tacrolimus—FKBP1A—medulla oblongata—Parkinson's disease	0.00213	0.0116	CbGeAlD
Tacrolimus—MTOR—spinal cord—Parkinson's disease	0.00211	0.0115	CbGeAlD
Tacrolimus—Temsirolimus—CYP2D6—Parkinson's disease	0.00199	0.427	CrCbGaD
Tacrolimus—FKBP1A—midbrain—Parkinson's disease	0.00194	0.0106	CbGeAlD
Tacrolimus—FKBP1A—spinal cord—Parkinson's disease	0.0019	0.0104	CbGeAlD
Tacrolimus—MTOR—head—Parkinson's disease	0.00187	0.0103	CbGeAlD
Tacrolimus—PPP3CA—brain—Parkinson's disease	0.00184	0.0101	CbGeAlD
Tacrolimus—MTOR—nervous system—Parkinson's disease	0.00178	0.00972	CbGeAlD
Tacrolimus—MTOR—central nervous system—Parkinson's disease	0.00171	0.00936	CbGeAlD
Tacrolimus—FKBP1A—head—Parkinson's disease	0.00169	0.00922	CbGeAlD
Tacrolimus—MTOR—cerebellum—Parkinson's disease	0.00167	0.00915	CbGeAlD
Tacrolimus—FKBP1A—nervous system—Parkinson's disease	0.0016	0.00875	CbGeAlD
Tacrolimus—FKBP1A—central nervous system—Parkinson's disease	0.00154	0.00842	CbGeAlD
Tacrolimus—FKBP1A—cerebellum—Parkinson's disease	0.0015	0.00823	CbGeAlD
Tacrolimus—ORM1—spinal cord—Parkinson's disease	0.00149	0.00813	CbGeAlD
Tacrolimus—Temsirolimus—ABCB1—Parkinson's disease	0.00142	0.305	CrCbGaD
Tacrolimus—MTOR—brain—Parkinson's disease	0.00136	0.00743	CbGeAlD
Tacrolimus—Sirolimus—ABCB1—Parkinson's disease	0.00125	0.268	CrCbGaD
Tacrolimus—ORM1—nervous system—Parkinson's disease	0.00125	0.00685	CbGeAlD
Tacrolimus—FKBP1A—brain—Parkinson's disease	0.00122	0.00668	CbGeAlD
Tacrolimus—ORM1—central nervous system—Parkinson's disease	0.0012	0.00659	CbGeAlD
Tacrolimus—ALB—brain—Parkinson's disease	0.000839	0.00459	CbGeAlD
Tacrolimus—ABCB1—embryo—Parkinson's disease	0.00077	0.00421	CbGeAlD
Tacrolimus—ABCB1—forebrain—Parkinson's disease	0.000681	0.00373	CbGeAlD
Tacrolimus—ABCB1—cardiovascular system—Parkinson's disease	0.000576	0.00315	CbGeAlD
Tacrolimus—CYP3A4—nervous system—Parkinson's disease	0.000522	0.00286	CbGeAlD
Tacrolimus—CYP3A4—central nervous system—Parkinson's disease	0.000503	0.00275	CbGeAlD
Tacrolimus—ABCB1—medulla oblongata—Parkinson's disease	0.000492	0.00269	CbGeAlD
Tacrolimus—ABCB1—midbrain—Parkinson's disease	0.00045	0.00246	CbGeAlD
Tacrolimus—ABCB1—spinal cord—Parkinson's disease	0.000439	0.0024	CbGeAlD
Tacrolimus—ABCB1—head—Parkinson's disease	0.00039	0.00213	CbGeAlD
Tacrolimus—ABCB1—nervous system—Parkinson's disease	0.00037	0.00202	CbGeAlD
Tacrolimus—ABCB1—central nervous system—Parkinson's disease	0.000356	0.00195	CbGeAlD
Tacrolimus—ABCB1—cerebellum—Parkinson's disease	0.000348	0.0019	CbGeAlD
Tacrolimus—ABCB1—brain—Parkinson's disease	0.000283	0.00155	CbGeAlD
Tacrolimus—MTOR—Downstream signaling of activated FGFR—IL6—Parkinson's disease	7.62e-05	0.000262	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—GCH1—Parkinson's disease	7.61e-05	0.000262	CbGpPWpGaD
Tacrolimus—MTOR—Cellular responses to stress—MAPK8—Parkinson's disease	7.55e-05	0.00026	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—PENK—Parkinson's disease	7.53e-05	0.000259	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—MAG—Parkinson's disease	7.53e-05	0.000259	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by ERBB4—IL6—Parkinson's disease	7.5e-05	0.000258	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—IGF1R—Parkinson's disease	7.43e-05	0.000255	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—ADRBK1—Parkinson's disease	7.34e-05	0.000252	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—EDN1—Parkinson's disease	7.34e-05	0.000252	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—INS—Parkinson's disease	7.28e-05	0.00025	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—TALDO1—Parkinson's disease	7.25e-05	0.000249	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—OMD—Parkinson's disease	7.25e-05	0.000249	CbGpPWpGaD
Tacrolimus—ALB—Folate Metabolism—IL6—Parkinson's disease	7.19e-05	0.000247	CbGpPWpGaD
Tacrolimus—MTOR—Downstream signal transduction—IL6—Parkinson's disease	7.17e-05	0.000246	CbGpPWpGaD
Tacrolimus—ALB—Transmembrane transport of small molecules—CP—Parkinson's disease	7.16e-05	0.000246	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by FGFR—IL6—Parkinson's disease	7.13e-05	0.000245	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—DRD2—Parkinson's disease	7.11e-05	0.000244	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—HTR7—Parkinson's disease	7.11e-05	0.000244	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—MTHFR—Parkinson's disease	7.1e-05	0.000244	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by ERBB2—IL6—Parkinson's disease	7.09e-05	0.000244	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by NGF—MAPK8—Parkinson's disease	7.09e-05	0.000244	CbGpPWpGaD
Tacrolimus—ALB—Selenium Micronutrient Network—TNF—Parkinson's disease	7.07e-05	0.000243	CbGpPWpGaD
Tacrolimus—MTOR—DAP12 signaling—IL6—Parkinson's disease	7.06e-05	0.000243	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—PDYN—Parkinson's disease	6.89e-05	0.000237	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—DDC—Parkinson's disease	6.89e-05	0.000237	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—FGB—Parkinson's disease	6.89e-05	0.000237	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—NDUFB11—Parkinson's disease	6.87e-05	0.000236	CbGpPWpGaD
Tacrolimus—ABCB1—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	6.82e-05	0.000235	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—GBA—Parkinson's disease	6.78e-05	0.000233	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—FBP1—Parkinson's disease	6.78e-05	0.000233	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—DBH—Parkinson's disease	6.78e-05	0.000233	CbGpPWpGaD
Tacrolimus—ABCB1—Allograft Rejection—TNF—Parkinson's disease	6.76e-05	0.000232	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—ND3—Parkinson's disease	6.75e-05	0.000232	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—MCCC1—Parkinson's disease	6.75e-05	0.000232	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—NGF—Parkinson's disease	6.75e-05	0.000232	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by FGFR in disease—IL6—Parkinson's disease	6.64e-05	0.000228	CbGpPWpGaD
Tacrolimus—MTOR—DAP12 interactions—IL6—Parkinson's disease	6.64e-05	0.000228	CbGpPWpGaD
Tacrolimus—MTOR—Fc epsilon receptor (FCERI) signaling—IL6—Parkinson's disease	6.64e-05	0.000228	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—APOE—Parkinson's disease	6.61e-05	0.000227	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by EGFR—IL6—Parkinson's disease	6.58e-05	0.000226	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—GCH1—Parkinson's disease	6.55e-05	0.000225	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by EGFR in Cancer—IL6—Parkinson's disease	6.52e-05	0.000224	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—GSTA4—Parkinson's disease	6.5e-05	0.000224	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by PDGF—IL6—Parkinson's disease	6.5e-05	0.000223	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—GFAP—Parkinson's disease	6.48e-05	0.000223	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—HTR2A—Parkinson's disease	6.42e-05	0.000221	CbGpPWpGaD
Tacrolimus—CYP3A4—Biological oxidations—COMT—Parkinson's disease	6.42e-05	0.000221	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—GRM5—Parkinson's disease	6.41e-05	0.00022	CbGpPWpGaD
Tacrolimus—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	6.39e-05	0.00022	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—ADRBK1—Parkinson's disease	6.39e-05	0.00022	CbGpPWpGaD
Tacrolimus—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	6.37e-05	0.000219	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—TALDO1—Parkinson's disease	6.35e-05	0.000218	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—OMD—Parkinson's disease	6.35e-05	0.000218	CbGpPWpGaD
Tacrolimus—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	6.33e-05	0.000218	CbGpPWpGaD
Tacrolimus—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	6.3e-05	0.000217	CbGpPWpGaD
Tacrolimus—ABCB1—Transmembrane transport of small molecules—CP—Parkinson's disease	6.28e-05	0.000216	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—NDUFB11—Parkinson's disease	6.02e-05	0.000207	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—APOE—Parkinson's disease	5.97e-05	0.000205	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—IGF2—Parkinson's disease	5.96e-05	0.000205	CbGpPWpGaD
Tacrolimus—PPP3CA—Innate Immune System—IL6—Parkinson's disease	5.92e-05	0.000203	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	5.91e-05	0.000203	CbGpPWpGaD
Tacrolimus—MTOR—Disease—ADRBK1—Parkinson's disease	5.9e-05	0.000203	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—IL1B—Parkinson's disease	5.89e-05	0.000202	CbGpPWpGaD
Tacrolimus—MTOR—NGF signalling via TRKA from the plasma membrane—IL6—Parkinson's disease	5.88e-05	0.000202	CbGpPWpGaD
Tacrolimus—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	5.87e-05	0.000202	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—PLA2G6—Parkinson's disease	5.86e-05	0.000201	CbGpPWpGaD
Tacrolimus—MTOR—Disease—HSPA1A—Parkinson's disease	5.85e-05	0.000201	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—DBH—Parkinson's disease	5.84e-05	0.000201	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—FBP1—Parkinson's disease	5.84e-05	0.000201	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—GBA—Parkinson's disease	5.84e-05	0.000201	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—MAOB—Parkinson's disease	5.8e-05	0.000199	CbGpPWpGaD
Tacrolimus—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	5.79e-05	0.000199	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—IGF1R—Parkinson's disease	5.76e-05	0.000198	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—GCH1—Parkinson's disease	5.74e-05	0.000197	CbGpPWpGaD
Tacrolimus—ALB—Selenium Micronutrient Network—IL6—Parkinson's disease	5.71e-05	0.000196	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—EDN1—Parkinson's disease	5.69e-05	0.000196	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—INS—Parkinson's disease	5.65e-05	0.000194	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—FGF20—Parkinson's disease	5.62e-05	0.000193	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—ADORA2A—Parkinson's disease	5.45e-05	0.000187	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—MAPK8—Parkinson's disease	5.4e-05	0.000186	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—NGF—Parkinson's disease	5.23e-05	0.00018	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—ABL1—Parkinson's disease	5.21e-05	0.000179	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—GBA—Parkinson's disease	5.12e-05	0.000176	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—FBP1—Parkinson's disease	5.12e-05	0.000176	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—DBH—Parkinson's disease	5.12e-05	0.000176	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—SOD1—Parkinson's disease	5.11e-05	0.000176	CbGpPWpGaD
Tacrolimus—ALB—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	5.1e-05	0.000176	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—INS—Parkinson's disease	5.1e-05	0.000175	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—INSR—Parkinson's disease	5.03e-05	0.000173	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—HTR2A—Parkinson's disease	4.98e-05	0.000171	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—DDC—Parkinson's disease	4.98e-05	0.000171	CbGpPWpGaD
Tacrolimus—ALB—Transmembrane transport of small molecules—CYCS—Parkinson's disease	4.9e-05	0.000169	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—HGF—Parkinson's disease	4.89e-05	0.000168	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—ABL1—Parkinson's disease	4.88e-05	0.000168	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—IGF2—Parkinson's disease	4.86e-05	0.000167	CbGpPWpGaD
Tacrolimus—MTOR—Cellular responses to stress—IL6—Parkinson's disease	4.82e-05	0.000166	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—FGB—Parkinson's disease	4.75e-05	0.000163	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—HTR1A—Parkinson's disease	4.73e-05	0.000163	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—GSTA4—Parkinson's disease	4.7e-05	0.000162	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—TAC1—Parkinson's disease	4.66e-05	0.00016	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—APOE—Parkinson's disease	4.63e-05	0.000159	CbGpPWpGaD
Tacrolimus—ALB—Hemostasis—HGF—Parkinson's disease	4.59e-05	0.000158	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	4.58e-05	0.000158	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—DRD1—Parkinson's disease	4.57e-05	0.000157	CbGpPWpGaD
Tacrolimus—MTOR—Signaling by NGF—IL6—Parkinson's disease	4.52e-05	0.000156	CbGpPWpGaD
Tacrolimus—ABCB1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	4.47e-05	0.000154	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—DRD3—Parkinson's disease	4.42e-05	0.000152	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—CYP2D6—Parkinson's disease	4.31e-05	0.000148	CbGpPWpGaD
Tacrolimus—ABCB1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	4.29e-05	0.000148	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—DDC—Parkinson's disease	4.29e-05	0.000147	CbGpPWpGaD
Tacrolimus—ALB—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	4.26e-05	0.000146	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—PLA2G6—Parkinson's disease	4.23e-05	0.000146	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—CTGF—Parkinson's disease	4.23e-05	0.000145	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	4.21e-05	0.000145	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—MAOB—Parkinson's disease	4.19e-05	0.000144	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—ND3—Parkinson's disease	4.16e-05	0.000143	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—MCCC1—Parkinson's disease	4.16e-05	0.000143	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—ADRBK1—Parkinson's disease	4.13e-05	0.000142	CbGpPWpGaD
Tacrolimus—ALB—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	4.09e-05	0.000141	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—GSTA4—Parkinson's disease	4.05e-05	0.000139	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—MAPK8—Parkinson's disease	4.04e-05	0.000139	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—HTR7—Parkinson's disease	4e-05	0.000137	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—DRD2—Parkinson's disease	4e-05	0.000137	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	4e-05	0.000137	CbGpPWpGaD
Tacrolimus—MTOR—Disease—MTHFR—Parkinson's disease	3.99e-05	0.000137	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—INS—Parkinson's disease	3.95e-05	0.000136	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—CYP2E1—Parkinson's disease	3.94e-05	0.000136	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—TALDO1—Parkinson's disease	3.91e-05	0.000135	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—OMD—Parkinson's disease	3.91e-05	0.000135	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—NQO1—Parkinson's disease	3.9e-05	0.000134	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—TH—Parkinson's disease	3.84e-05	0.000132	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—CASP3—Parkinson's disease	3.8e-05	0.000131	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling by GPCR—IL6—Parkinson's disease	3.77e-05	0.00013	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—DDC—Parkinson's disease	3.76e-05	0.000129	CbGpPWpGaD
Tacrolimus—ABCB1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	3.73e-05	0.000128	CbGpPWpGaD
Tacrolimus—MTOR—Disease—APOE—Parkinson's disease	3.72e-05	0.000128	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	3.71e-05	0.000128	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—CYCS—Parkinson's disease	3.69e-05	0.000127	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—PLA2G6—Parkinson's disease	3.65e-05	0.000125	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—MAOB—Parkinson's disease	3.61e-05	0.000124	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—GSTA4—Parkinson's disease	3.55e-05	0.000122	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—GCH1—Parkinson's disease	3.54e-05	0.000122	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—MAPK8—Parkinson's disease	3.49e-05	0.00012	CbGpPWpGaD
Tacrolimus—PPP3CA—Immune System—IL6—Parkinson's disease	3.45e-05	0.000119	CbGpPWpGaD
Tacrolimus—ALB—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	3.44e-05	0.000118	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—IGF2—Parkinson's disease	3.35e-05	0.000115	CbGpPWpGaD
Tacrolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	3.33e-05	0.000115	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—COMT—Parkinson's disease	3.27e-05	0.000112	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—GSTP1—Parkinson's disease	3.25e-05	0.000112	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—MAOA—Parkinson's disease	3.24e-05	0.000111	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—IGF1R—Parkinson's disease	3.24e-05	0.000111	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—HMOX1—Parkinson's disease	3.21e-05	0.00011	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—EDN1—Parkinson's disease	3.2e-05	0.00011	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—PLA2G6—Parkinson's disease	3.19e-05	0.00011	CbGpPWpGaD
Tacrolimus—PPP3CA—Disease—IL6—Parkinson's disease	3.18e-05	0.000109	CbGpPWpGaD
Tacrolimus—MTOR—Disease—INS—Parkinson's disease	3.18e-05	0.000109	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—MAOB—Parkinson's disease	3.16e-05	0.000109	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—FBP1—Parkinson's disease	3.15e-05	0.000108	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—GBA—Parkinson's disease	3.15e-05	0.000108	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—DBH—Parkinson's disease	3.15e-05	0.000108	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—CYP2D6—Parkinson's disease	3.11e-05	0.000107	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—ABCB1—Parkinson's disease	3.08e-05	0.000106	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—CTGF—Parkinson's disease	3.06e-05	0.000105	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—GSTM1—Parkinson's disease	2.99e-05	0.000103	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—CASP3—Parkinson's disease	2.94e-05	0.000101	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—NGF—Parkinson's disease	2.94e-05	0.000101	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—GPX1—Parkinson's disease	2.86e-05	9.83e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—CYP2E1—Parkinson's disease	2.85e-05	9.8e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—NQO1—Parkinson's disease	2.82e-05	9.69e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—HTR2A—Parkinson's disease	2.8e-05	9.63e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—TH—Parkinson's disease	2.78e-05	9.55e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—MAPK8—Parkinson's disease	2.71e-05	9.3e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—CYP2D6—Parkinson's disease	2.68e-05	9.22e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—CYCS—Parkinson's disease	2.67e-05	9.17e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—MTHFR—Parkinson's disease	2.64e-05	9.08e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—CTGF—Parkinson's disease	2.63e-05	9.05e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—APOE—Parkinson's disease	2.6e-05	8.95e-05	CbGpPWpGaD
Tacrolimus—MTOR—Innate Immune System—IL6—Parkinson's disease	2.58e-05	8.87e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—IL1B—Parkinson's disease	2.57e-05	8.83e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Disease—IL6—Parkinson's disease	2.47e-05	8.48e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—APOE—Parkinson's disease	2.46e-05	8.45e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—CYP2E1—Parkinson's disease	2.45e-05	8.44e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—NQO1—Parkinson's disease	2.43e-05	8.34e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—TH—Parkinson's disease	2.39e-05	8.22e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—COMT—Parkinson's disease	2.36e-05	8.12e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—MAPK8—Parkinson's disease	2.35e-05	8.09e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—CYP2D6—Parkinson's disease	2.35e-05	8.08e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—GSTP1—Parkinson's disease	2.35e-05	8.08e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—MAOA—Parkinson's disease	2.34e-05	8.06e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—HMOX1—Parkinson's disease	2.32e-05	7.97e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—DDC—Parkinson's disease	2.31e-05	7.96e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—CTGF—Parkinson's disease	2.31e-05	7.93e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—CYCS—Parkinson's disease	2.3e-05	7.89e-05	CbGpPWpGaD
Tacrolimus—PPP3CA—Signaling Pathways—IL6—Parkinson's disease	2.23e-05	7.66e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—INS—Parkinson's disease	2.22e-05	7.65e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—ABCB1—Parkinson's disease	2.22e-05	7.65e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—GSTA4—Parkinson's disease	2.19e-05	7.52e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—GSTM1—Parkinson's disease	2.16e-05	7.42e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—CYP2E1—Parkinson's disease	2.15e-05	7.39e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—NQO1—Parkinson's disease	2.13e-05	7.31e-05	CbGpPWpGaD
Tacrolimus—CYP3A7—Metabolism—INS—Parkinson's disease	2.1e-05	7.22e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—TH—Parkinson's disease	2.09e-05	7.2e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—GPX1—Parkinson's disease	2.07e-05	7.11e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—COMT—Parkinson's disease	2.03e-05	6.99e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—GSTP1—Parkinson's disease	2.02e-05	6.96e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—MAOA—Parkinson's disease	2.02e-05	6.94e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—CYCS—Parkinson's disease	2.01e-05	6.92e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—HMOX1—Parkinson's disease	2e-05	6.86e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	1.97e-05	6.77e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—MAOB—Parkinson's disease	1.95e-05	6.7e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—ABCB1—Parkinson's disease	1.92e-05	6.59e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—MTHFR—Parkinson's disease	1.91e-05	6.56e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—GSTM1—Parkinson's disease	1.86e-05	6.39e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—COMT—Parkinson's disease	1.78e-05	6.12e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—GPX1—Parkinson's disease	1.78e-05	6.12e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—APOE—Parkinson's disease	1.78e-05	6.11e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—GSTP1—Parkinson's disease	1.77e-05	6.1e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—MAOA—Parkinson's disease	1.77e-05	6.08e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—HMOX1—Parkinson's disease	1.75e-05	6.01e-05	CbGpPWpGaD
Tacrolimus—FKBP1A—Signaling Pathways—IL6—Parkinson's disease	1.73e-05	5.94e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—CASP3—Parkinson's disease	1.66e-05	5.69e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—MTHFR—Parkinson's disease	1.64e-05	5.65e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—GSTM1—Parkinson's disease	1.63e-05	5.6e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—GPX1—Parkinson's disease	1.56e-05	5.36e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—APOE—Parkinson's disease	1.53e-05	5.26e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—MAPK8—Parkinson's disease	1.52e-05	5.23e-05	CbGpPWpGaD
Tacrolimus—CYP3A5—Metabolism—INS—Parkinson's disease	1.52e-05	5.22e-05	CbGpPWpGaD
Tacrolimus—MTOR—Immune System—IL6—Parkinson's disease	1.5e-05	5.17e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	1.45e-05	4.98e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—MTHFR—Parkinson's disease	1.44e-05	4.95e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—CTGF—Parkinson's disease	1.42e-05	4.89e-05	CbGpPWpGaD
Tacrolimus—MTOR—Disease—IL6—Parkinson's disease	1.39e-05	4.77e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—APOE—Parkinson's disease	1.34e-05	4.61e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	1.32e-05	4.55e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—NQO1—Parkinson's disease	1.31e-05	4.5e-05	CbGpPWpGaD
Tacrolimus—ALB—Metabolism—INS—Parkinson's disease	1.31e-05	4.49e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—TH—Parkinson's disease	1.29e-05	4.44e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—CYCS—Parkinson's disease	1.24e-05	4.26e-05	CbGpPWpGaD
Tacrolimus—ABCB1—Metabolism—INS—Parkinson's disease	1.15e-05	3.94e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—COMT—Parkinson's disease	1.1e-05	3.77e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—GSTP1—Parkinson's disease	1.09e-05	3.76e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—MAOA—Parkinson's disease	1.09e-05	3.75e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—HMOX1—Parkinson's disease	1.08e-05	3.7e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—ABCB1—Parkinson's disease	1.03e-05	3.56e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—GSTM1—Parkinson's disease	1e-05	3.45e-05	CbGpPWpGaD
Tacrolimus—MTOR—Signaling Pathways—IL6—Parkinson's disease	9.72e-06	3.34e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—GPX1—Parkinson's disease	9.61e-06	3.31e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—MTHFR—Parkinson's disease	8.87e-06	3.05e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—APOE—Parkinson's disease	8.26e-06	2.84e-05	CbGpPWpGaD
Tacrolimus—CYP3A4—Metabolism—INS—Parkinson's disease	7.06e-06	2.43e-05	CbGpPWpGaD
